“…However, although CRISPR-Cas systems confer tangible benefits, there are associated fitness costs (Vale et al., 2015, Westra et al., 2015). Hence, multiple systems are transcriptionally regulated (Arslan et al., 2013), which might enable physiological responsiveness to a changing environment and, thereby, a net cost-benefit balance. Since bacterial defensive requirements are predicted to change relative to population density (Abedon, 2012), we hypothesized that CRISPR-Cas immunity could be integrated into the host QS circuit, allowing increased defense at higher cell densities.…”